May 9, 2026, 08:19
ASRM Joins Major Medical Groups in Defending Access to Mifepristone – ASRM
American Society for Reproductive Medicine – ASRM shared a post on LinkedIn։
“ASRM is proud to join The Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists (ACOG), and other leading medical organizations in demanding that mifepristone, a safe and effective medication used in abortion and miscarriage care, remains accessible to the patients who need it.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 28, 2026, 17:35Saeed Fathi: Turning AI Innovation into Meaningful Clinical Impact in Fertility Care
-
Sep 28, 2026, 17:31Caspian Ostadian: Fresh vs Frozen Embryo Transfer – Which One Is Better?
-
Sep 28, 2026, 17:28Keshav Malhotra: Bringing the 2nd Edition of RESET to Da Nang, Vietnam
-
Sep 28, 2026, 17:25Christina Walker: Novel Biomarkers for PCOS and DOR
-
Sep 28, 2026, 17:18An Opportunity to Raise Awareness of the Importance of Safe, Accessible Abortion Care – RCOG
-
Sep 28, 2026, 17:13Stephany El-Hayek: From Embryology Intern to Mama and Founder of A Good Start
-
Sep 28, 2026, 17:09Apratim Arora: The Confidence Graph of a Clinical Embryologist
-
Sep 28, 2026, 17:06Vikrant Bhatia: Healthcare Has the Data, But Are We Truly Learning From It?
-
Sep 28, 2026, 17:02Abdelrahman H. Daifalla: DISS IVF – Clinical Intelligence for Reproductive Medicine